World Ankylosing Spondylitis Market Research Report 2023 (Covering USA, Europe, China, Japan, India and etc)

Publication ID:

ICRW12180003

Publication Date:

December 03, 2018

Pages:

111

Publisher:

ICRW

Region:

Global [1]

$2,960.00

Description:

Summary
Ankylosing Spondylitis market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Ankylosing Spondylitis Market: Product Segment Analysis
Disease-modifying anitrheumatic drugs (DMARDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Biologics
Other
Global Ankylosing Spondylitis Market: Application Segment Analysis
Ankylosing spondylitis (AS) in adults
Juvenile ankylosing spondylitis (JAS)
Application 3
Application 4
Global Ankylosing Spondylitis Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Abbvie
Amgen
Merck & Co.
Boehringer Ingelheim
Celgene
Celltrion
Eisai
F. Hoffmann-La Roche
Novartis
Janssen Pharmaceuticals
Regeneron Pharmaceuticals
Sanofi
UCB
Xian janssen
Celgen Biopharma

Table Of Contents:

Table of Content

Chapter 1 About the Ankylosing Spondylitis Industry
1.1 Industry Definition and Types
1.1.1 Disease-modifying anitrheumatic drugs (DMARDs)
1.1.2 Nonsteroidal anti-inflammatory drugs (NSAIDs)
1.1.3 Biologics
1.1.1.4 Other
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape
2.1 Ankylosing Spondylitis Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.1.3 China
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.1.4 India
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2013-2018
Sales and Growth Rate 2013-2018
Major Players
2.2 World Ankylosing Spondylitis Market by Types
Disease-modifying anitrheumatic drugs (DMARDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Biologics
Other
2.3 World Ankylosing Spondylitis Market by Applications
Ankylosing spondylitis (AS) in adults
Juvenile ankylosing spondylitis (JAS)
Application 3
Application 4
2.4 World Ankylosing Spondylitis Market Analysis
2.4.1 World Ankylosing Spondylitis Market Revenue and Growth Rate 2013-2018
2.4.2 World Ankylosing Spondylitis Market Consumption and Growth rate 2013-2018
2.4.3 World Ankylosing Spondylitis Market Price Analysis 2013-2018

Chapter 3 World Ankylosing Spondylitis Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2018, Through 2023
3.4 Major Revenue (M USD) Market share By Regions in 2018, Through 2023

Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2013-2018
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis

Chapter 5 Company Profiles
5.1 Abbvie
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 Amgen
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Merck & Co.
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 Boehringer Ingelheim
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Celgene
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Celltrion
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Eisai
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 F. Hoffmann-La Roche
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 Novartis
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Janssen Pharmaceuticals
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Regeneron Pharmaceuticals
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Sanofi
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 UCB
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
5.14 Xian janssen
5.14.1 Company Details (Foundation Year, Employee Strength and etc)
5.14.2 Product Information (Picture, Specifications and Applications)
5.14.3 Revenue (M USD), Price and Operating Profits
5.15 Celgen Biopharma
5.15.1 Company Details (Foundation Year, Employee Strength and etc)
5.15.2 Product Information (Picture, Specifications and Applications)
5.15.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry

Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India

Chapter 9 World Ankylosing Spondylitis Market Forecast through 2023
9.1 World Ankylosing Spondylitis Demand by Regions Forecast through 2023
9.2 World Ankylosing Spondylitis Price(by Regions, Types, Applications)Analysis Forecast through 2023
9.3 World Ankylosing Spondylitis Revenue (M USD)(by Regions, Types, Applications) Forecast through 2023
9.4 World Ankylosing Spondylitis Market Analysis
9.4.1 World Ankylosing Spondylitis Market Revenue and Growth Rate 2013-2018
9.4.2 World Ankylosing Spondylitis Market Consumption and Growth rate 2013-2018
9.4.3 World Ankylosing Spondylitis Market Price Analysis 2013-2018

Chapter 10 Key success factors and Market Overview

Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2013-2018
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2013-2018
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2013-2018
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2013-2018
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2013-2018
Table Major Players
Table Major Production Market share by Players 2017
Table Major Revenue (M USD) Market share by Players 2017
Table Production Market share by Major Regions in 2013-2018
Table Production Market share by Major Regions in 2018-2023
Table Revenue (M USD) Market share by Regions in 2013-2018
Table Revenue (M USD) Market share by Regions in 2018-2023
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2013-2018
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Abbvie Information List
Figure Ankylosing SpondylitisAnkylosing Spondylitis Picture, Specifications and Applications of Abbvie
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Abbvie 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Abbvie 2017-2018
Table Amgen Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Amgen
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Amgen 2017-2018
Table Merck & Co. Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Merck & Co.
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Merck & Co. 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Merck & Co. 2017-2018
Table Boehringer Ingelheim Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Boehringer Ingelheim
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Boehringer Ingelheim 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Boehringer Ingelheim 2017-2018
Table Celgene Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celgene
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celgene 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celgene 2017-2018
Table Celltrion Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celltrion
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celltrion 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celltrion 2017-2018
Table Eisai Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Eisai
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eisai 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Eisai 2017-2018
Table F. Hoffmann-La Roche Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of F. Hoffmann-La Roche
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of F. Hoffmann-La Roche 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of F. Hoffmann-La Roche 2017-2018
Table Novartis Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Novartis
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Novartis 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Novartis 2017-2018
Table Janssen Pharmaceuticals Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Janssen Pharmaceuticals
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Janssen Pharmaceuticals 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Janssen Pharmaceuticals 2017-2018
Table Regeneron Pharmaceuticals Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Regeneron Pharmaceuticals
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Regeneron Pharmaceuticals 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Regeneron Pharmaceuticals 2017-2018
Table Sanofi Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Sanofi
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Sanofi 2017-2018
Table UCB Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of UCB
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of UCB 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of UCB 2017-2018
Table Xian janssen Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Xian janssen
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Xian janssen 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Xian janssen 2017-2018
Table Celgen Biopharma Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celgen Biopharma
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celgen Biopharma 2017-2018
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celgen Biopharma 2017-2018
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Price by Regions Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Price by Types Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Price by Applications Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Revenue (M USD) by Regions Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Revenue (M USD) by Types Forecast Analysis of Ankylosing Spondylitis (2018-2023)
Table World Revenue (M USD) by Applications Forecast Analysis of Ankylosing Spondylitis (2018-2023)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.